Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 8, 2021
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
David Nierengarten Maintained (ARGX) at Buy with Decreased Target to $344 on, Jun 8th, 2021
David Nierengarten of Wedbush, Maintained "argenx SE" (ARGX) at Buy with Decreased Target from $356 to $344 on, Jun 8th, 2021.
David has made no other calls on ARGX in the last 4 months.
There are 3 other peers that have a rating on ARGX. Out of the 3 peers that are also analyzing ARGX, 0 agree with David's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with David
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $324 on, Tuesday, May 18th, 2021
- Douglas Tsao of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $400 on, Monday, May 10th, 2021
- Yaron Werber of "Cowen & Co." Maintained at Buy with Increased Target to $430 on, Thursday, February 18th, 2021
